Standardized Concentrations Needed For Pediatric Cough/Cold Safety – CDER
This article was originally published in The Tan Sheet
Standardizing the concentrations of ingredients in OTC cough/cold products would help reduce confusion between formulations for children and those for infants, FDA's Center for Drug Evaluation and Research recommends
You may also be interested in...
FDA does not go far enough with its recent public health advisory on pediatric cough/cold OTCs to address the potential severe adverse events described in a citizen petition recommending labeling changes to the products, according to one of the petitioners
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.